Budget Amount *help |
¥3,900,000 (Direct Cost: ¥3,000,000、Indirect Cost: ¥900,000)
Fiscal Year 2014: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
Fiscal Year 2013: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
|
Outline of Final Research Achievements |
Group 3 innate lymphoid cell (ILC3) develops RORgt dependent manner and plays critical roles on maintaining mucosal barrier function. In this study, with genetic strategy to dissect T cell and ILC3 development pathway, I generated new mouse model in which ILC3 can be depleted. After double strand DNA break with CRISPR/Cas9 system, loxp franked Diphteria toxin (DTR) transgene was knocked-in to the RORgt locus. I could observe DTR expression on one of the knock-in founders. I am generating ILC3 specifically deletable mice by crossing this KI founders with T cell specific Cre mouse lines.
|